EXAS Historical PE Ratio image   This EXAS PE ratio history page last updated 4/28/2022
EXAS PE History Chart
PeriodPriceGAAPTTMPE
Q1 2022
4/26/2022
58.63-1.04-4.14NA
Q4 2021
2/22/2022
73.45-1.28-3.28NA
Q3 2021
11/2/2021
95.63-0.79-2.15NA
Q2 2021
7/28/2021
116.06-1.03-1.43NA
Q1 2021
5/4/2021
116.02-0.18-0.98NA
Q4 2020
2/16/2021
154.28-0.15-1.46NA
Q3 2020
10/27/2020
131.12-0.07-1.68NA
Q2 2020
7/30/2020
97.90-0.58-1.92NA
Q1 2020
5/6/2020
77.90-0.66-1.64NA
Q4 2019
2/11/2020
94.83-0.37-1.56NA
Q3 2019
10/29/2019
90.61-0.31-1.63NA
Q2 2019
7/29/2019
117.57-0.30-1.69NA
Q1 2019
4/30/2019
98.69-0.58-1.69NA
Q4 2018
2/21/2019
83.28-0.44-1.44NA
Q3 2018
10/30/2018
64.40-0.37-1.18NA
Q2 2018
8/1/2018
59.12-0.30-1.04NA
Q1 2018
4/26/2018
46.60-0.33-1.01NA
Q4 2017
2/22/2018
44.99-0.18-1.00NA
Q3 2017
10/30/2017
50.10-0.23-1.16NA
Q2 2017
7/25/2017
37.33-0.27-1.29NA
Q1 2017
4/27/2017
30.14-0.32-1.48NA
Q4 2016
2/21/2017
22.41-0.34-1.65NA
Q3 2016
10/26/2016
16.73-0.36-1.72NA
Q2 2016
7/26/2016
16.21-0.46-1.81NA
Q1 2016
5/3/2016
6.35-0.49-1.79NA
Q4 2015
2/24/2016
5.87-0.41-1.70NA
Q3 2015
10/29/2015
7.15-0.45-1.67NA
Q2 2015
7/20/2015
27.03-0.44-1.61NA
Q1 2015
5/4/2015
24.44-0.40-1.41NA
Q4 2014
2/24/2015
22.90-0.38-1.24NA
Q3 2014
10/27/2014
23.61-0.39-1.03NA
Q2 2014
7/22/2014
16.49-0.24-0.80NA
Q1 2014
5/1/2014
12.56-0.23-0.75NA
Q4 2013
2/20/2014
13.45-0.17-0.69NA
Q3 2013
10/29/2013
11.03-0.16-0.74NA
Q2 2013
7/23/2013
13.48-0.19-0.79NA
Q1 2013
5/1/2013
9.05-0.17-0.86NA
Q4 2012
2/20/2013
10.57-0.22-0.88NA
Q3 2012
10/30/2012
NA-0.21NANA
Q2 2012
7/25/2012
10.02-0.26NANA
Q1 2012
5/1/2012
10.33-0.19NANA
EXAS Historical PE Ratio Chart
Data adjusted for EXAS split history

PeriodPriceGAAPAnnualizedPE
Q1 2022
4/26/2022
58.63-1.04-4.16NA
Q4 2021
2/22/2022
73.45-1.28-5.12NA
Q3 2021
11/2/2021
95.63-0.79-3.16NA
Q2 2021
7/28/2021
116.06-1.03-4.12NA
Q1 2021
5/4/2021
116.02-0.18-0.72NA
Q4 2020
2/16/2021
154.28-0.15-0.60NA
Q3 2020
10/27/2020
131.12-0.07-0.28NA
Q2 2020
7/30/2020
97.90-0.58-2.32NA
Q1 2020
5/6/2020
77.90-0.66-2.64NA
Q4 2019
2/11/2020
94.83-0.37-1.48NA
Q3 2019
10/29/2019
90.61-0.31-1.24NA
Q2 2019
7/29/2019
117.57-0.30-1.20NA
Q1 2019
4/30/2019
98.69-0.58-2.32NA
Q4 2018
2/21/2019
83.28-0.44-1.76NA
Q3 2018
10/30/2018
64.40-0.37-1.48NA
Q2 2018
8/1/2018
59.12-0.30-1.20NA
Q1 2018
4/26/2018
46.60-0.33-1.32NA
Q4 2017
2/22/2018
44.99-0.18-0.72NA
Q3 2017
10/30/2017
50.10-0.23-0.92NA
Q2 2017
7/25/2017
37.33-0.27-1.08NA
Q1 2017
4/27/2017
30.14-0.32-1.28NA
Q4 2016
2/21/2017
22.41-0.34-1.36NA
Q3 2016
10/26/2016
16.73-0.36-1.44NA
Q2 2016
7/26/2016
16.21-0.46-1.84NA
Q1 2016
5/3/2016
6.35-0.49-1.96NA
Q4 2015
2/24/2016
5.87-0.41-1.64NA
Q3 2015
10/29/2015
7.15-0.45-1.80NA
Q2 2015
7/20/2015
27.03-0.44-1.76NA
Q1 2015
5/4/2015
24.44-0.40-1.60NA
Q4 2014
2/24/2015
22.90-0.38-1.52NA
Q3 2014
10/27/2014
23.61-0.39-1.56NA
Q2 2014
7/22/2014
16.49-0.24-0.96NA
Q1 2014
5/1/2014
12.56-0.23-0.92NA
Q4 2013
2/20/2014
13.45-0.17-0.68NA
Q3 2013
10/29/2013
11.03-0.16-0.64NA
Q2 2013
7/23/2013
13.48-0.19-0.76NA
Q1 2013
5/1/2013
9.05-0.17-0.68NA
Q4 2012
2/20/2013
10.57-0.22-0.88NA
Q3 2012
10/30/2012
NA-0.21-0.84NA
Q2 2012
7/25/2012
10.02-0.26-1.04NA
Q1 2012
5/1/2012
10.33-0.19-0.76NA
Quotes delayed 20 minutes

Email EnvelopeFree EXAS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Exact Sciences (EXAS) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

EXEL PE Ratio History
EYE PE Ratio History
EYEG PE Ratio History
EYEN PE Ratio History
EYES PE Ratio History
EYPT PE Ratio History
FATE PE Ratio History
FBIO PE Ratio History
FBRX PE Ratio History
FDMT PE Ratio History
On this page we presented the EXAS PE Ratio History information for Exact Sciences' stock. The average EXAS PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average EXAS PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this EXAS PE ratio history result, against the recent PE: when this page was posted on 4/27/2022, the most recent closing price for EXAS had been 62.52, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on EXAS or any other given stock, valuation analysis for EXAS can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Exact Sciences PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for EXAS. Thanks for visiting, and the next time you need to research EXAS PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: OVL Videos, SBII Average Annual Return, IVR YTD Return.

 

EXAS PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.